Not applicableStudy completedNCT05905939What this trial is testingHER2(Human Epidermal Growth Factor Receptor 2) -Positive Metastatic Breast Cancer in RussiaWho this might be right forBreast Cancer AstraZeneca 774
Testing effectiveness (Phase 2)Study completedNCT01565083What this trial is testingAssess Efficacy and Safety of Pertuzumab Given in Combination With Trastuzumab and Vinorelbine in Participants With Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive Breast CancerWho this might be right forBreast Cancer Hoffmann-La Roche 213
Testing effectiveness (Phase 2)Ended earlyNCT01394211What this trial is testingNeo-adjuvant Therapy With Anastrozole Plus Pazopanib in Stage II and III ER+ Breast CancerWho this might be right forEstrogen Receptor-positive Breast CancerHuman Epidermal Growth Factor 2 Negative Carcinoma of BreastMale Breast Cancer+4 more University of Arizona 2
Large-scale testing (Phase 3)Study completedNCT00605267What this trial is testingArimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal TreatmentWho this might be right forBreast Cancer AstraZeneca 197
Testing effectiveness (Phase 2)WithdrawnNCT05191004What this trial is testingStudy of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBCWho this might be right forAdvanced Breast CancerMetastatic Breast CancerBreast Cancer+5 more Nuvation Bio Inc.
Testing effectiveness (Phase 2)Ended earlyNCT04424641What this trial is testingA Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid TumorsWho this might be right forLocally Advanced or Metastatic Solid Tumor(s)Prostate CancerEsophageal Cancer+5 more Genmab 48
Early research (Phase 1)Study completedNCT02960594What this trial is testingHTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of RelapseWho this might be right forBreast CancerLung CancerPancreatic Cancer+6 more Inovio Pharmaceuticals 93
Not applicableStudy completedNCT01730365What this trial is testingOptical Detection of Malignancy During Percutaneous InterventionsWho this might be right forPulmonary Coin LesionColon Cancer Liver MetastasisBreast Cancer Philips Healthcare 104
Testing effectiveness (Phase 2)Study completedNCT05549505What this trial is testingA Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to SurgeryWho this might be right forBreast Cancer Arvinas Inc. 152
Not applicableNot Yet RecruitingNCT07593196What this trial is testingHER2-positive Metastatic Breast Cancer in KazakhstanWho this might be right forMetastatic Breast Cancer AstraZeneca 240
Not applicableStudy completedNCT04498481What this trial is testingTREATMENT AND MONITORING PATTERNS AND CLINICAL OUTCOMES IN PATIENTS RECEIVING PALBOCICLIB COMBINATION TREATMENT (WITH AI OR FULVESTRANT) FOR HR+/HER2- A/MBC IN A COMMUNITY ONCOLOGY SETTING.Who this might be right forBreast Cancer Pfizer 1
Not applicableStudy completedNCT00842465What this trial is testingProlactin Receptor and Breast DiseasesWho this might be right forBenign Breast DiseaseBreast Cancer Assistance Publique - Hôpitaux de Paris 735
Early research (Phase 1)Study completedNCT00003107What this trial is testingInterleukin-12 in Treating Patients With Hematologic Cancers or Solid TumorsWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more Indiana University
Not applicableUnknownNCT02656589What this trial is testingMicroRNA of Human Epidermal Growth Factor Receptor 2 （HER2）Positive Patient Treated With HerceptinWho this might be right forBreast Cancer Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT04225117What this trial is testingEvaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)Who this might be right forLocally Advanced or Metastatic Malignant Solid Tumors Astellas Pharma Global Development, Inc. 329
Testing effectiveness (Phase 2)Study completedNCT02481050What this trial is testingStudy to Evaluate the Efficacy and Safety of Eribulin Mesylate Administered Biweekly (Q2W) for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Metastatic Breast CancerWho this might be right forBreast Cancer Eisai Inc. 58
Testing effectiveness (Phase 2)Ended earlyNCT00817362What this trial is testingEfficacy and Safety of IPI-504 With Trastuzumab Pretreated, Locally Advanced or Metastatic HER2 Positive Breast CancerWho this might be right forBreast CancerHER2 Positive Breast CancerMetastatic Breast Cancer+1 more Infinity Pharmaceuticals, Inc. 29
Testing effectiveness (Phase 2)UnknownNCT03906669What this trial is testingA Window of Opportunity Study of Pre-operative Endocrine Therapy With and Without Prometrium in Postmenopausal Women With Early Stage Breast Hormone Receptor Positive (HR+) Human Epidermal Receptor 2 Negative (HER2-) Breast Cancer.Who this might be right forEarly-stage Breast CancerHormone Receptor Positive Tumor St Vincent's Hospital 200
Testing effectiveness (Phase 2)Study completedNCT02988986What this trial is testingTAK-228 Plus Tamoxifen in Patients With ER-Positive, HER2-negative Breast CancerWho this might be right forEstrogen Receptor Positive Breast Cancer The Methodist Hospital Research Institute 28
Early research (Phase 1)Active Not RecruitingNCT05143970What this trial is testingFirst-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid TumorsWho this might be right forMetastatic CancerMetastatic Breast CancerMetastatic Pancreatic Cancer+6 more Institut Paoli-Calmettes 27